Matrix-mini-tablets of lornoxicam for targeting early morning peak symptoms of rheumatoid arthritis

Matrix-mini-tablets of lornoxicam for targeting early morning peak symptoms of rheumatoid arthritis

Objective(s): The aim of present research was to develop matrix-mini-tablets of lornoxicam filled in capsule for targeting early morning peak symptoms of rheumatoid arthritis. Materials and Methods:Matrix-mini-tablets of lornoxicam were prepared by direct compression method using microsomal enzyme d...

Full description

Bibliographic Details
Main Authors:	Abdul Hadi Mohd, Nidagurthi Guggilla Raghavendra Rao, Srinivasa Rao Avanapu
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2014-05-01
Series:	Iranian Journal of Basic Medical Sciences
Subjects:	Lornoxicam Matrix-mini-tablets-filled-capsule system Microsomal enzyme depen- dent polymers pH-sensitive polymers rheumatoid arthritis
Online Access:	http://ijbms.mums.ac.ir/pdf_2786_4998782b83db06316dc3d89f521bacbf.html

Similar Items

Design and evaluation of lornoxicam bilayered tablets for biphasic release
by: Songa Ambedkar Sunil, et al.
Published: (2012-12-01)

Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design (QbD) Approach
by: Nawaf Almotairi, et al.
Published: (2022-11-01)

RP-HPLC assay method development for Paracetamol and Lornoxicam in combination and characterization of oxidative degradation products of Lornoxicam
by: Jain Pritam S., et al.
Published: (2013-01-01)

Lornoxicam use to reduce the pain associated with propofol injection
by: Nihal Başak, et al.
Published: (2017-01-01)

β- Galactosidase mediated release characteristics of lornoxicam loaded guar gum microspheres: evaluation and product development
by: Abdesh Singh, et al.
Published: (2015-12-01)

Kinetic Study of Lornoxicam Hydrolysis
by: sawsan hasan hammodi, et al.
Published: (2020-02-01)

Pediatric Mini-Tablets: Predicting the Hidden Risk of Fill Errors
by: Brandon G. Gerberich, et al.
Published: (2023-02-01)

Transdermal Delivery of Lornoxicam Hybrid Nanogel: Design, Preparation, Characterization, and In-Vitro Diffusion Evaluation
by: Hayder Kadhim Drais
Published: (2023-10-01)

The synergistic antinociceptive effect of lornoxicam in combination with tramadol
by: Amela Saračević, et al.
Published: (2013-12-01)

Mini-Tablets versus Nanoparticles for Controlling the Release of Amoxicillin: In vitro/In vivo Study
by: Gaber DA, et al.
Published: (2020-12-01)

The effect of exercise training on the level of tissue IL-6 and vascular endothelial growth factor in breast cancer bearing mice
by: Sadegh Amani Shalamzari, et al.
Published: (2014-04-01)

Acupuncture versus Lornoxicam in the Treatment of Acute Renal Colic: A Randomized Controlled Trial
by: Zhang X, et al.
Published: (2021-11-01)

Tableting of mini-tablets in comparison with conventionally sized tablets: A comparison of tableting properties and tablet dimensions
by: Ard Lura, et al.
Published: (2020-12-01)

A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study
by: Teaima MH, et al.
Published: (2021-10-01)

Lornoxicam-Loaded Cubosomes: - Preparation and In vitro Characterization.
by: Rasha Saadi Younus Alkawak, et al.
Published: (2022-06-01)

Comparing Early Postoperative Period Analgesic Effect of Dexketoprofene Trometamol and Lornoxicam in Mediastinoscopy Cases
by: Gonul Sagiroglu
Published: (2011-04-01)

Comparison of tramadol and lornoxicam in intravenous regional anesthesia: a randomized controlled trial
by: Hande Çelik, et al.
Published: (2016-02-01)

Comparison of tramadol and lornoxicam for the prevention of postoperative catheter-related bladder discomfort: a randomized controlled trial
by: Xin Liao, et al.
Published: (2023-06-01)

Immunomodulatory Effects of the Cyclooxygenase Inhibitor Lornoxicam on Phenotype and Function of Camel Blood Leukocytes
by: Jamal Hussen, et al.
Published: (2021-07-01)

Effects of Omega-3 Co-Administered with Therapeutic Dose of lornoxicam on Male Rats' Liver
by: Israa A. Majeed, et al.
Published: (2019-12-01)

Effects of lornoxicam and intravenous ibuprofen on erythrocyte deformability and hepatic and renal blood flow in rats
by: Arpacı H, et al.
Published: (2016-08-01)

Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use
by: Jiayu Hu, et al.
Published: (2023-01-01)

Comparison between lornoxicam quick-release and parecoxib for post-operative analgesia after laparoscopic cholecystectomy: A prospective randomized, placebo-controlled trial
by: Irene Kouroukli, et al.
Published: (2013-01-01)

Can the preemptive use of lornoxicam or paracetamol prevent pain after inguinal hernia repair? A randomized prospective double-blind placebo controlled trial
by: Alp Alptekin, et al.
Published: (2022-01-01)

A validated stability-indicating RP-HPLC method for paracetamol and lornoxicam: Application to pharmaceutical dosage forms
by: Karunakaran Kulandaivelu, et al.
Published: (2014-01-01)

Risperidone oral disintegrating mini-tablets: A robust-product for pediatrics
by: El-Say Khalid M., et al.
Published: (2015-12-01)

Assessment of lornoxicam as a mouth dissolving film in management of post extraction pain-A randomized control trial
by: M Aparna Vijayan, et al.
Published: (2022-01-01)

Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery
by: Gönüllü Ümit, et al.
Published: (2015-03-01)

Lornoxicam-Loaded Chitosan-Decorated Nanoemulsion: Preparation and In Vitro Evaluation for Enhanced Transdermal Delivery
by: Rahman Ullah Khan, et al.
Published: (2022-05-01)

Process of depenalization in Iranian criminal justice
by: valiollah sadeghi
Published: (2019-11-01)

3D Printing of Mini Tablets for Pediatric Use
by: Julius Krause, et al.
Published: (2021-02-01)

Design and dermatokinetic appraisal of lornoxicam-loaded ultrafine self-nanoemulsion hydrogel for the management of inflammation: In vitro and in vivo studies
by: Saleh A. Al-Suwayeh, et al.
Published: (2023-06-01)

Slovak Criminal Justice and the Philosophy of Its Privatization: An Appropriate Solution of Problems of Slovak Justice in the 21st Century?
by: Bystrík Šramel, et al.
Published: (2020-02-01)

Acceptability, Swallowability, Palatability, and Safety of Multiple Film-Coated Mini-Tablets in Children Aged ≥2–<7 Years: Results of an Open-Label Randomised Study
by: Juliane Münch, et al.
Published: (2023-02-01)

Tablet Disintegration and Dispersion under In Vivo-like Hydrodynamic Conditions
by: Jan Lenz, et al.
Published: (2022-01-01)

Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study
by: Juliane Münch, et al.
Published: (2023-06-01)

The amount of liquid patients use to take tablets or capsules
by: Fuchs J
Published: (2009-09-01)

Pharmaceutical Development of Film-Coated Mini-Tablets with Losartan Potassium for Epidermolysis Bullosa
by: Valentinë Elezaj, et al.
Published: (2022-03-01)

Development and Evaluation of Feline Tailored Amlodipine Besylate Mini-Tablets Using L-lysine as a Candidate Flavouring Agent
by: Chinedu S. Ekweremadu, et al.
Published: (2020-09-01)

Development and Optimization of Sildenafil Orodispersible Mini-Tablets (ODMTs) for Treatment of Pediatric Pulmonary Hypertension Using Response Surface Methodology
by: Ahmed Alalaiwe, et al.
Published: (2023-03-01)